The HbA1c reductions reported in the phase 2 diabetes trial are comparable in magnitude to those reported for dedicated diabetes medications
Moderate levels of cellular iron are essential for maintaining normal bone health
Harris, Jon Harmon Feldman, Jeff Melvoin) in its first season
Cellular adhesions marked by endogenous paxillin-GFP were labeled with anti-GFP primary antibodies (Life Technologies, Carlsbad, CA, USA, Cat# A-11122, RRID:AB_221569, dilution: 1:500) and Anti-Rabbit Alexa Fluor 488 secondary antibodies (Invitrogen/Fisher Scientific, Goat Polyclonal, Cat# A-11008, RRID:AB_143165, dilution: 1:500) in the m-EGFP-tagged Paxillin (PXN) WTC iPSC line, while the actin cytoskeleton was labeled with Acti-stain 488 (Cytoskeleton, Inc., Denver, CO, USA, Cat# PHDG1-A) in the TagBFP-tagged d-Cas9-KRAB WTC iPSC lines